学术探索
学术期刊
新闻热点
数据分析
智能评审

Issues related to targeted delivery of proteins and peptides

被引：74
作者：
Lu, Yingjuan
Yang, Jun
Sega, Emanuela
机构：
[1] Endocyte Inc, W Lafayette, IN 47906 USA
[2] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
来源：
AAPS JOURNAL | 2006年 / 8卷 / 03期
关键词：
targeted delivery; protein therapeutics; peptide therapeutics; cancer therapy;
D O I：
10.1208/aapsj080355
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
While modern genomic and proteomic technology enables rapid screening of novel proteins and peptides as potential drug candidates, design of delivery systems for these biologics remains challenging especially to achieve site-specific pharmacological actions. This article discusses the issues associated with targeted delivery of protein and peptide drugs at physiochemical, physiological, and intracellular levels with a special focus on cancer therapy.
引用
收藏
页码：E466 / E478
页数：13
相关论文
共 113 条
  • [91] Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-α and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors
    Sampson, JH
    Akabani, G
    Archer, GE
    Bigner, DD
    Berger, MS
    Friedman, AH
    Friedman, HS
    Herndon, JE
    Kunwar, S
    Marcus, S
    McLendon, RE
    Paolino, A
    Penne, K
    Provenzale, J
    Quinn, J
    Reardon, DA
    Rich, J
    Stenzel, T
    Tourt-Uhlig, S
    Wikstrand, C
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2003, 65 (01) : 27 - 35
  • [92] Schally AV, 2000, PROSTATE, V45, P158, DOI 10.1002/1097-0045(20001001)45:2<158::AID-PROS10>3.0.CO
  • [93] 2-K
  • [94] Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis
    Schally, AV
    [J]. PEPTIDES, 1999, 20 (10) : 1247 - 1262
  • [95] Chemotherapy targeted to cancers through tumoral hormone receptors
    Schally, AV
    Nagy, A
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2004, 15 (07) : 300 - 310
  • [96] New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin
    Schally, AV
    Nagy, A
    [J]. LIFE SCIENCES, 2003, 72 (21) : 2305 - 2320
  • [97] Immunogenicity of therapeutic proteins: Clinical implications and future prospects
    Schellekens, H
    [J]. CLINICAL THERAPEUTICS, 2002, 24 (11) : 1720 - 1740
  • [98] Detection of colon cancer with 99mTc-labeled bombesin derivative (99mTc-leu13-BN1)
    Scopinaro, F
    De Vincentis, G
    Corazziari, E
    Massa, R
    Osti, M
    Pallotta, N
    Covotta, A
    Remediani, S
    Di Paolo, M
    Monteleone, F
    Varvarigou, A
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (02) : 245 - 252
  • [99] Selbo PK, 2000, INT J CANCER, V87, P853, DOI 10.1002/1097-0215(20000915)87:6<853::AID-IJC15>3.0.CO
  • [100] 2-0
3456789101112